Elevance Health analysts hold a steady view, consensus frames the ELV shares

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 10:23.

Elevance Health (US2855211023) stands as one of the larger managed-care names on the NYSE and in the S&P 500 healthcare segment. The ELV ticker gives investors exposure to the US health insurance market with a pronounced emphasis on commercial plans and government programs.

How analysts currently rate ELV

Sell-side coverage for Elevance Health centers on earnings visibility, medical cost trends and membership growth in commercial and Medicare Advantage plans. Typical consensus patterns for large US payers show a majority of Buy or Overweight ratings and a smaller share of Hold recommendations, reflecting perceived defensive qualities in the sector.

Analyst models for Elevance Health generally track adjusted earnings per share growth over the next 12 to 24 months, factoring in premium growth, utilization trends and the impact of value-based care contracts. For a stock like ELV, multi-year EPS compound annual growth assumptions in the high single digits to low double digits are common among major Wall Street houses when medical costs are broadly contained.

Consensus estimates and focus points

Consensus estimates on Elevance Health typically bundle views from global houses such as Goldman Sachs, JPMorgan and Morgan Stanley plus sector specialists at Citi, BofA and Barclays. These firms scrutinize the company’s ability to balance pricing with competitive pressure while keeping the medical loss ratio within management’s guided corridor.

Beyond earnings per share, analysts focus on revenue growth in the company’s Health Benefits segment and services businesses as well as operating margin stability. They pay close attention to the contribution from Medicare Advantage and Medicaid, where regulatory changes and risk adjustment fine-tuning can shift profitability year by year.

What the company sells

Elevance Health generates most of its revenue by offering health insurance plans and related services to employers, individuals and public-sector programs. A representative product is its Anthem-branded commercial health plans, which combine medical coverage with pharmacy benefits and care management services for US corporate clients.

Where the stock trades today

Elevance Health shares (US2855211023) trade on the NYSE under the symbol ELV, giving investors liquid exposure in US dollars to the US managed-care sector; price and market-cap values depend on the latest intraday quote and are not fixed in this article.

This article is for informational purposes only and does not constitute investment advice, tax advice or a recommendation to buy or sell securities. All data are based on publicly available information interpreted by the AD HOC NEWS editorial desk at the time of review.